ATE455792T1 - Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon - Google Patents

Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon

Info

Publication number
ATE455792T1
ATE455792T1 AT04805350T AT04805350T ATE455792T1 AT E455792 T1 ATE455792 T1 AT E455792T1 AT 04805350 T AT04805350 T AT 04805350T AT 04805350 T AT04805350 T AT 04805350T AT E455792 T1 ATE455792 T1 AT E455792T1
Authority
AT
Austria
Prior art keywords
sequence
pharmaceutical compositions
binding protein
compositions containing
containing same
Prior art date
Application number
AT04805350T
Other languages
English (en)
Inventor
Eric Chabriere
Carlos Contreras-Martel
Juan Fontecilla-Camps
Original Assignee
Centre Nat Rech Scient
Univ Henri Poincare Nancy I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Henri Poincare Nancy I filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE455792T1 publication Critical patent/ATE455792T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04805350T 2003-10-30 2004-10-29 Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon ATE455792T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312729A FR2861731B1 (fr) 2003-10-30 2003-10-30 Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
PCT/FR2004/002797 WO2005042572A1 (fr) 2003-10-30 2004-10-29 Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations

Publications (1)

Publication Number Publication Date
ATE455792T1 true ATE455792T1 (de) 2010-02-15

Family

ID=34429758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805350T ATE455792T1 (de) 2003-10-30 2004-10-29 Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon

Country Status (11)

Country Link
US (1) US7718773B2 (de)
EP (1) EP1678204B1 (de)
JP (1) JP4728246B2 (de)
CN (1) CN1898261B (de)
AT (1) ATE455792T1 (de)
CA (1) CA2543935C (de)
DE (1) DE602004025265D1 (de)
ES (1) ES2341174T3 (de)
FR (1) FR2861731B1 (de)
IL (1) IL175319A (de)
WO (1) WO2005042572A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
CA2635430A1 (en) * 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
DK2275132T3 (da) 2005-12-29 2021-05-17 Boehringer Ingelheim Animal Health Usa Inc Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem
WO2008064299A2 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
WO2008073464A2 (en) * 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2094872T (pt) * 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (de) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
FR2942717B1 (fr) * 2009-03-04 2011-08-12 Centre Nat Rech Scient Nouvel agent antiviral
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
US20140018288A1 (en) * 2012-07-16 2014-01-16 St. Luke's-Roosevelt Hospital Center X-DING-CD4 Peptide
ES2778425T3 (es) 2013-10-02 2020-08-10 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2334905A1 (en) * 1998-06-12 1999-12-23 Gordon J. Hoover Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents
US20030158115A1 (en) * 2000-03-28 2003-08-21 Toback F. Gary Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells

Also Published As

Publication number Publication date
FR2861731B1 (fr) 2006-02-24
ES2341174T3 (es) 2010-06-16
JP4728246B2 (ja) 2011-07-20
FR2861731A1 (fr) 2005-05-06
CA2543935C (fr) 2014-12-02
CN1898261B (zh) 2011-08-17
IL175319A (en) 2013-07-31
EP1678204A1 (de) 2006-07-12
US20070196879A1 (en) 2007-08-23
IL175319A0 (en) 2006-09-05
WO2005042572A1 (fr) 2005-05-12
CN1898261A (zh) 2007-01-17
JP2008502305A (ja) 2008-01-31
CA2543935A1 (fr) 2005-05-12
DE602004025265D1 (de) 2010-03-11
US7718773B2 (en) 2010-05-18
EP1678204B1 (de) 2010-01-20

Similar Documents

Publication Publication Date Title
DE602004025265D1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
AU2002305450A1 (en) Proteomimetic compounds and methods
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
MX2008009493A (es) Peptido novedoso y uso del mismo.
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
ATE495247T1 (de) Chromoprotein und fluoroproteine
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
AU2003251728A1 (en) Placental growth factor as a target for the treatment of osteoporosis
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
ATE291587T1 (de) Somatostatin analoge und deren verwendung zur behandlung von krebs
WO2005086595A3 (ja) テロメアタンパク質ｔｒｆ２ｄｎａ結合ドメイン変異体タンパク質、テロメアｄｎａ変異体及びｔｒｆ２ｄｎａ結合ドメインと二重らせんｄｎａとの複合体構造の利用
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
PT1401871E (pt) Moleculas de ligacao imunologicas que inibem a fusao sincicial de celulas do tropoblasto
WO2009014160A1 (ja) 膵癌の新規腫瘍マーカー
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
DE60312497D1 (de) Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika
NZ603077A (en) Biological materials and uses thereof
WO2004011491A3 (en) Peptidyl-trna hydrolase of enterococcus faecalis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties